HEADER BIOSYNTHETIC PROTEIN 03-OCT-23 8QPY TITLE SOLUTION NMR STRUCTURE OF THE PEPTIDYL CARRIER DOMAIN TOMAPCP FROM THE TITLE 2 TOMAYMYCIN NON-RIBOSOMAL PEPTIDE SYNTHETASE COMPND MOL_ID: 1; COMPND 2 MOLECULE: CARRIER PROTEIN TOMAPCP; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 OTHER_DETAILS: FIRST FOUR RESIDUES (GPMA) IN THE PROTEIN ARE FROM COMPND 6 CLONING ARTIFACTS. THEREFORE, THE APPROPRIATE RESIDUE NUMBERING HAS COMPND 7 THE FIRST RESIDUE (G) DESIGNATED AS RESIDUE-NUMBER '-3', SO THAT THE COMPND 8 FIFTH RESIDUE HAS RESIDUE-NUMBER '1'. A SPECIAL MODIFIED RESIDUE SPP COMPND 9 IS DESIGNATED FOR THE SERINE RESIDUE COVALENTLY LINKED TO A 4'- COMPND 10 PHOSPHOPANTETHEINE PROSTHETIC GROUP. SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: STREPTOMYCES REGENSIS; SOURCE 3 ORGANISM_TAXID: 68263; SOURCE 4 VARIANT: FH6421; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008 KEYWDS NON-RIBOSOMAL PEPTIDE SYNTHETASE, TOMAYMYCIN, PCP, KEYWDS 2 PHOSPHOPANTETHEINE, DONOR, BIOSYNTHETIC PROTEIN EXPDTA SOLUTION NMR NUMMDL 10 AUTHOR M.N.KARANTH,J.P.KIRKPATRICK,T.CARLOMAGNO REVDAT 2 03-JUL-24 8QPY 1 JRNL REVDAT 1 26-JUN-24 8QPY 0 JRNL AUTH M.N.KARANTH,J.P.KIRKPATRICK,J.KRAUSZE,S.SCHMELZ,A.SCRIMA, JRNL AUTH 2 T.CARLOMAGNO JRNL TITL THE SPECIFICITY OF INTERMODULAR RECOGNITION IN A JRNL TITL 2 PROTOTYPICAL NONRIBOSOMAL PEPTIDE SYNTHETASE DEPENDS ON AN JRNL TITL 3 ADAPTOR DOMAIN. JRNL REF SCI ADV V. 10 M9404 2024 JRNL REFN ESSN 2375-2548 JRNL PMID 38896613 JRNL DOI 10.1126/SCIADV.ADM9404 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.21, CNS 1.21, CNS 1.21 REMARK 3 AUTHORS : BRUNGER, ADAMS, CLORE, GROS, NILGES AND READ REMARK 3 (CNS), BRUNGER, ADAMS, CLORE, GROS, NILGES AND REMARK 3 READ (CNS), BRUNGER, ADAMS, CLORE, GROS, NILGES REMARK 3 AND READ (CNS) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8QPY COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 03-OCT-23. REMARK 100 THE DEPOSITION ID IS D_1292133510. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 308 REMARK 210 PH : 7.0 REMARK 210 IONIC STRENGTH : 265 REMARK 210 PRESSURE : 1 ATM REMARK 210 SAMPLE CONTENTS : 500 UM [U-13C; U-15N] APCP, 50 REMARK 210 MM SODIUM PHOSPHATE, 150 MM REMARK 210 SODIUM CHLORIDE, 5 MM DTT, 10 V/ REMARK 210 V [U-2H] D2O, 0.02 % W/V SODIUM REMARK 210 AZIDE, 90% H2O/10% D2O; 500 UM REMARK 210 [U-13C; U-15N] APCP, 50 MM REMARK 210 SODIUM PHOSPHATE, 150 MM SODIUM REMARK 210 CHLORIDE, 5 MM DTT, 0.02 W/V REMARK 210 SODIUM AZIDE, 100 % V/V [U-2H] REMARK 210 D2O, 100% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-15N HSQC; 3D HNCO; 3D REMARK 210 HNCA; 3D CBCA(CO)NH; 3D HNCACB; REMARK 210 3D H(CCO)NH; 3D C(CO)NH; 3D HCCH- REMARK 210 TOCSY; 3D HBHA(CO)NH; 3D 1H-15N REMARK 210 NOESY; 2D 1H-13C HSQC; 2D REMARK 210 HBCBCGCDHDGP; 2D HBCBCGCDCEHEGP; REMARK 210 3D 1H-13C NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ; 800 MHZ; 850 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE III; AVANCE III HD REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : TOPSPIN 3.2, NMRPIPE 10.2, REMARK 210 CCPNMR ANALYSIS 2.4, ARIA 2.3 REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 10 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 9 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 ALA A 0 -70.66 -86.28 REMARK 500 1 ALA A 2 -82.71 66.93 REMARK 500 1 ASP A 23 35.36 -82.14 REMARK 500 1 LEU A 31 45.16 -58.47 REMARK 500 1 4HH A 37 -143.31 -82.80 REMARK 500 1 LEU A 38 -13.94 -40.81 REMARK 500 2 VAL A 3 99.03 67.26 REMARK 500 2 ASP A 22 -49.69 -149.02 REMARK 500 2 LEU A 31 48.20 -60.50 REMARK 500 2 ASN A 36 -35.80 -131.55 REMARK 500 2 4HH A 37 -142.73 -104.74 REMARK 500 2 LEU A 38 -15.30 -38.72 REMARK 500 2 ARG A 81 88.53 -68.48 REMARK 500 2 ASN A 82 82.14 55.52 REMARK 500 2 ALA A 84 47.98 -152.64 REMARK 500 2 GLN A 86 86.35 55.93 REMARK 500 3 PRO A -2 -71.00 -60.43 REMARK 500 3 MET A -1 -39.87 -151.88 REMARK 500 3 THR A 1 -63.59 75.98 REMARK 500 3 ASP A 23 40.57 -82.77 REMARK 500 3 LEU A 31 47.45 -60.85 REMARK 500 3 4HH A 37 -141.39 -106.56 REMARK 500 3 LEU A 38 -15.43 -40.07 REMARK 500 3 ASN A 82 62.11 -156.10 REMARK 500 3 GLN A 86 -56.47 -157.06 REMARK 500 4 ALA A 2 59.56 -119.06 REMARK 500 4 4HH A 37 -143.51 -110.57 REMARK 500 4 LEU A 38 -17.12 -41.27 REMARK 500 4 ALA A 84 63.07 -151.46 REMARK 500 5 ASP A 22 -54.50 -138.25 REMARK 500 5 ASP A 23 41.39 -81.44 REMARK 500 5 4HH A 37 -143.64 -110.86 REMARK 500 5 LEU A 38 -16.96 -40.05 REMARK 500 6 MET A -1 -83.48 64.83 REMARK 500 6 GLN A 4 -52.86 72.78 REMARK 500 6 ASP A 23 40.38 -81.56 REMARK 500 6 LEU A 31 48.75 -59.35 REMARK 500 6 4HH A 37 -141.22 -110.26 REMARK 500 6 LEU A 38 -16.53 -37.13 REMARK 500 6 THR A 79 -78.14 -103.89 REMARK 500 6 ARG A 81 -156.72 -128.69 REMARK 500 6 ALA A 84 -52.76 -138.09 REMARK 500 7 ASP A 22 -76.07 -113.25 REMARK 500 7 ASP A 23 40.25 -85.94 REMARK 500 7 LEU A 31 49.15 -56.70 REMARK 500 7 4HH A 37 -143.22 -110.04 REMARK 500 7 LEU A 38 -15.73 -40.98 REMARK 500 7 ASN A 82 89.75 55.84 REMARK 500 7 ALA A 84 22.36 -153.86 REMARK 500 7 GLN A 86 85.20 -170.65 REMARK 500 REMARK 500 THIS ENTRY HAS 70 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 34868 RELATED DB: BMRB REMARK 900 SOLUTION NMR STRUCTURE OF THE PEPTIDYL CARRIER DOMAIN TOMAPCP FROM REMARK 900 THE TOMAYMYCIN NON-RIBOSOMAL PEPTIDE SYNTHETASE DBREF 8QPY A -3 88 PDB 8QPY 8QPY -3 88 SEQRES 1 A 92 GLY PRO MET ALA THR ALA VAL GLN ASN PRO LEU GLU THR SEQRES 2 A 92 VAL VAL LEU GLN ALA TRP LYS ASP ILE SER GLY ALA ASP SEQRES 3 A 92 ASP PHE THR THR THR ASP SER PHE LEU GLY HIS GLY GLY SEQRES 4 A 92 ASN 4HH LEU HIS PHE VAL GLN LEU ALA SER ARG LEU GLN SEQRES 5 A 92 LYS ILE PHE GLY VAL GLU VAL SER THR GLU ASP VAL PHE SEQRES 6 A 92 ARG HIS GLY THR VAL GLU GLN LEU ALA ARG PHE VAL GLU SEQRES 7 A 92 GLN SER ARG ASP THR GLY ARG ASN PRO ALA ALA GLN THR SEQRES 8 A 92 GLN MODRES 8QPY 4HH A 37 SER MODIFIED RESIDUE HET 4HH A 37 52 HETNAM 4HH 4'-PHOSPHOPANTHETHEINE-SERINE HETSYN 4HH O-[(S)-HYDROXY{[(3R)-3-HYDROXY-2,2-DIMETHYL-4-OXO-4- HETSYN 2 4HH ({3-OXO-3-[(2-SULFANYLETHYL)AMINO]PROPYL}AMINO) HETSYN 3 4HH BUTYL]OXY}PHOSPHORYL]-L-SERINE FORMUL 1 4HH C14 H28 N3 O9 P S HELIX 1 AA1 PRO A 6 SER A 19 1 14 HELIX 2 AA2 LEU A 38 PHE A 51 1 14 HELIX 3 AA3 THR A 57 HIS A 63 1 7 HELIX 4 AA4 VAL A 66 SER A 76 1 11 LINK C ASN A 36 N 4HH A 37 1555 1555 1.31 LINK C 4HH A 37 N LEU A 38 1555 1555 1.33 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1